=Procter & Gamble (PG) reported earnings on Fri 19 Oct 2018 (b/o)

Procter & Gamble beats by $0.03, beats on revs; reaffirms core FY19 EPS and revenue guidance 

• Reports Q1 (Sep) earnings of $1.12 per share, excluding non-recurring items, $0.03 better than the S&P Capital IQ Consensus of $1.09; revenues rose 0.2% year/year to $16.69 bln vs the $16.45 bln S&P Capital IQ Consensus. 
• Organic sales increased four percent driven by a three percent increase in shipment volume. Positive mix impact was a one percent help to organic sales due to the disproportionate organic growth of the Skin and Personal Care and Personal Health Care categories and strong growth in the United States. Pricing was neutral to the quarter.
• Co issues guidance for FY19, sees EPS +3-8% to ~$4.35-4.56, excluding non-recurring items, vs. $4.37 S&P Capital IQ Consensus; sees FY19 revs of flat to down 2% to ~$65.50-66.83 bln vs. $66.58 bln S&P Capital IQ Consensus. P&G said it is maintaining its guidance for organic sales growth in the range of two to three percent for fiscal 2019. On a currency-neutral basis, this guidance translates to Core EPS growth of eleven to sixteen percent.